WallStreetZenWallStreetZen

NASDAQ: CMPS
Compass Pathways PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CMPS

Based on 5 analysts offering 12 month price targets for Compass Pathways PLC

Min Forecast
$11.00+208.12%
Avg Forecast
$20.20+465.83%
Max Forecast
$45.00+1,160.5%

Should I buy or sell CMPS stock?

Based on 5 analysts offering ratings for Compass Pathways PLC.

Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CMPS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CMPS as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their CMPS stock forecasts and price targets.

CMPS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-04
lockedlocked$00.00+00.00%2025-02-28
lockedlocked$00.00+00.00%2025-02-27
lockedlocked$00.00+00.00%2025-01-15
lockedlocked$00.00+00.00%2024-11-01

1 of 1

Forecast return on equity

Is CMPS forecast to generate an efficient return?

Company
8.39%
Industry
24.37%
Market
81.63%
CMPS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CMPS forecast to generate an efficient return on assets?

Company
6.07%
Industry
5.59%
CMPS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CMPS earnings per share forecast

What is CMPS's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$1.91
Avg 2 year Forecast
-$1.70
Avg 3 year Forecast
-$1.37

CMPS revenue forecast

What is CMPS's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$50.7M
Avg 2 year Forecast
$28.0M
Avg 3 year Forecast
$240.5M

CMPS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
CMPS$3.57$20.20+465.83%Strong Buy
CYH$2.41$3.28+35.89%Sell
EHAB$7.29$8.75+20.03%Buy
INNV$2.76$5.00+81.16%Strong Sell
SNDA$20.91$25.00+19.56%Hold
View Top Medical Care Facility Stocks

Compass Pathways Stock Forecast FAQ

Is Compass Pathways Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: CMPS) stock is to Strong Buy CMPS stock.

Out of 5 analysts, 3 (60%) are recommending CMPS as a Strong Buy, 2 (40%) are recommending CMPS as a Buy, 0 (0%) are recommending CMPS as a Hold, 0 (0%) are recommending CMPS as a Sell, and 0 (0%) are recommending CMPS as a Strong Sell.

If you're new to stock investing, here's how to buy Compass Pathways stock.

What is CMPS's earnings growth forecast for 2025-2027?

(NASDAQ: CMPS) Compass Pathways's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 9.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.12%.

Compass Pathways's earnings in 2025 is -$155,122,000.On average, 6 Wall Street analysts forecast CMPS's earnings for 2025 to be -$177,163,226, with the lowest CMPS earnings forecast at -$235,389,755, and the highest CMPS earnings forecast at -$119,548,340. On average, 4 Wall Street analysts forecast CMPS's earnings for 2026 to be -$157,776,007, with the lowest CMPS earnings forecast at -$217,781,860, and the highest CMPS earnings forecast at -$116,768,146.

In 2027, CMPS is forecast to generate -$126,962,191 in earnings, with the lowest earnings forecast at -$168,665,100 and the highest earnings forecast at -$85,259,281.

What is CMPS's revenue growth forecast for 2026-2028?

(NASDAQ: CMPS) Compass Pathways's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.33%.

Compass Pathways's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast CMPS's revenue for 2026 to be $4,698,527,792, with the lowest CMPS revenue forecast at $4,698,527,792, and the highest CMPS revenue forecast at $4,698,527,792. On average, 1 Wall Street analysts forecast CMPS's revenue for 2027 to be $2,594,847,696, with the lowest CMPS revenue forecast at $2,594,847,696, and the highest CMPS revenue forecast at $2,594,847,696.

In 2028, CMPS is forecast to generate $22,287,888,246 in revenue, with the lowest revenue forecast at $22,287,888,246 and the highest revenue forecast at $22,287,888,246.

What is CMPS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CMPS) forecast ROA is 6.07%, which is higher than the forecast US Medical Care Facilities industry average of 5.59%.

What is CMPS's Price Target?

According to 5 Wall Street analysts that have issued a 1 year CMPS price target, the average CMPS price target is $20.20, with the highest CMPS stock price forecast at $45.00 and the lowest CMPS stock price forecast at $11.00.

On average, Wall Street analysts predict that Compass Pathways's share price could reach $20.20 by Mar 4, 2026. The average Compass Pathways stock price prediction forecasts a potential upside of 465.83% from the current CMPS share price of $3.57.

What is CMPS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CMPS) Compass Pathways's current Earnings Per Share (EPS) is -$2.30. On average, analysts forecast that CMPS's EPS will be -$1.91 for 2025, with the lowest EPS forecast at -$2.54, and the highest EPS forecast at -$1.29. On average, analysts forecast that CMPS's EPS will be -$1.70 for 2026, with the lowest EPS forecast at -$2.35, and the highest EPS forecast at -$1.26. In 2027, CMPS's EPS is forecast to hit -$1.37 (min: -$1.82, max: -$0.92).

What is CMPS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CMPS) forecast ROE is 8.39%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.